External Source

Guggenheim Securities' Vamil Divan Breaks Down Merck's Stock Drop

2025 2:47

Vamil Divan, Guggenheim Securities biopharmaceutical analyst, joins 'Power Lunch' to discuss Merck's troubles in China.

Choose a download method below. All links open in new tabs.

Service	Features	Action
SaveFrom	MP4 & MP3 • HD Quality • Browser Extension Available	Download

Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.